BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from arou

Beginning its sixth year as an industry event, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.


It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.


The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in Boston in September 2012, panel discussions included licensing, investment and business development executives from Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Genentech, Genzyme, Gilead, Ironwood, Janssen Global Services, Merck, Nycomed, Pfizer, and Shire. The event attracted 750+ delegates from 462 companies who participated in 1,840+ scheduled one-to-one meetings.


For information about the BioPharm America 2013 program and registration information, please register your email address for regular updates from EBD Group at .

More details

Find an actor

4à6 de BioAlps - Selexis SA20.09.2017

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

new funding opportunity for ‘Young Researchers’ Exchange Programme’ between Switzerland and Korea

20 fellowships PhD students and young postdocs from Swiss and Korean Universities and Research Institutes
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn